Receptor Agonists News Today

Among 26 ResMed-supported abstracts, these were the highlights: New findings show positive airway pressure therapy reduced risks of death and hospitalization for patients with obstructive sleep...

Representing the real-world population in clinical trials is one of the most important factors in clinical studies.

Discover how GLP-1 receptor agonists like Ozempic are changing the game for ASCs, from anesthesia to care coordination and even orthopedics.

FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label updates and changes.

FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label updates and changes.

Good news: suicidal ideation is, according to the Food and Drug Administration, probably not among the list of bizarre side effects associated with semaglutide, the active ingredient in the diabetes injectable Ozempic and its weight management sister drug Wegovy. As the FDA said in a press release, the agency hasn't yet found any "clear relationship" between […]

The Food and Drug Administration (FDA) is looking into reports of adverse side effects from using diabetes medications such as Ozempic and Mounjaro, with hair loss, suicidal thoughts and airway obstruction being among the reported complications. According to the latest information from the agency, the FDA Adverse Event Reporting System (FAERS) received reports of patients…

The "Global Glucagon-like Peptide 1 (GLP-1) Market (by Product, Route of Administration, & Region): Insights and Forecast with Potential Impact of COVID-19 (2022-2027)" report has been added to ResearchAndMarkets.com's offering.

The panel committee reviewed non-clinical, clinical and post-marketing data of the drugs, and said that no updates to their prescribing information was required at the time. The agency has since April been monitoring the use of GLP-1 receptor agonists, a class of diabetes and weight loss drugs that includes Ozempic and Wegovy, for any signs that they increase the risk of thyroid cancer. The safety panel reviewed data from Novo's popular diabetes drug Ozempic and weight loss treatment Wego...

The topic of this article will revolve around Semaglutide peptide and hypoglycemia studies.